On March 24, 2026, GoodRx Holdings, Inc. disclosed in an 8-K filing that Romin Nabiey has resigned from his position as Chief Accounting Officer, effective April 3, 2026. The resignation is attributed to Mr. Nabiey’s decision to pursue other opportunities. However, he will continue to be employed by the company until June 8, 2026, to assist in the transition of his responsibilities. The company has expressed gratitude for Mr. Nabiey’s contributions during his tenure. This leadership change may raise concerns regarding the stability of the financial reporting function at GoodRx, potentially impacting investor confidence. The company has not indicated any disagreements between Mr. Nabiey and the management regarding operational policies or practices, which is a positive aspect of this transition. Nevertheless, leadership changes can often lead to uncertainty in the short term, particularly in financial roles that are critical for compliance and reporting. Investors will be watching closely to see how the company manages this transition and whether it will affect its financial performance and governance controls moving forward.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.